MYNX VASCULAR CLOSURE DEVICE PRODUCT FAMILY
FDA premarket approval P040044/S069 · decided 2016-01-31
Approval details
- PMA number
- P040044
- Supplement
- S069
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- MYNX VASCULAR CLOSURE DEVICE PRODUCT FAMILY
- Generic name
- Device, hemostasis, vascular
- Applicant
- Cordis US Corporation
- Date received
- 2016-01-05
- Decision date
- 2016-01-31
- Days to decision
- 26 days
- Decision code
- OK30
- Product code
- MGB
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Miami Lakes, FL
- Statement
- TO SOURCE POLYETHYLENE GLYCOL (PEG) RAW MATERIALS USED IN THE HYDROGEL SEALANT OF MYNX DEVICES FROM AN ALTERNATE MANUFACTURING FACILITY.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.